Tejnaksh Health.

Market Cap: Micro Cap
Industry: Healthcare Services
ISIN: INE030T01027
NSEID:
BSEID: 539428

INR

16.19

0.46 (2.92%)

BSENSE

Dec 04

BSE+NSE Vol: 16.88 k

{
  "main_header": {
    "sid": 999962,
    "name": "Tejnaksh Health.",
    "stock_name": "Tejnaksh Health.",
    "full_name": "Tejnaksh Healthcare Ltd",
    "name_url": "stocks-analysis/tejnaksh-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.19",
    "chg": 0.46,
    "chgp": "2.92%",
    "dir": 1,
    "prev_price": "15.73",
    "mcapval": "32.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539428,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE030T01027",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "16.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tejnaksh-health-999962-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tejnaksh Healthcare Faces Market Assessment Shift Amidst Challenging Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3745601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TejnakshHealthc_mojoScore_3745601.png",
        "date": "2025-12-04 08:14:52",
        "description": "Tejnaksh Healthcare, a player in the healthcare services sector, has recently experienced a notable shift in market evaluation metrics. This change reflects a complex interplay of technical indicators, valuation considerations, financial trends, and quality assessments, highlighting the challenges the company faces amid a subdued market environment and persistent underperformance relative to benchmarks."
      },
      {
        "title": "Why is Tejnaksh Health. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-tejnaksh-health-fallingrising-3744983",
        "imagepath": "",
        "date": "2025-12-04 00:48:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Underperformance Against Benchmarks</strong></p>\n<p>Tejnaksh Healthcare's recent price action reflects a persistent weakness relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.82%, markedly worse than the Sensex's modest 0.59% loss. The one-month performance further emphasises this divergence, with Tejnaksh Healthcare falling 11.76% while the Sensex gained 1.34%. Year-to-date figures reveal an even starker contrast: the stock has lost 30.70% of its value, whereas the Sensex has appreciated by 8.92%. This underperformance extends over longer horizons, with the stock down 34.73% over the last year and a staggering 73.93% over three years, while the Sensex has delivered positive returns of 5.27% and 35.37% respectively during these periods.</p>..."
      },
      {
        "title": "How has been the historical performance of Tejnaksh Health.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-tejnaksh-health-3744742",
        "imagepath": "",
        "date": "2025-12-03 22:51:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, Tejnaksh Health.'s net sales demonstrated a downward trend from ₹19.76 crores in 2019 to ₹12.90 crores in 2025. The peak sales were recorded in 2019, followed by a notable decline in subsequent years, with a slight recovery in the latest fiscal year. Total operating income mirrored this pattern, reflecting the company’s core business activity without other operating income contributions, which remained nil throughout.</p>\n<p>Despite the decline in sales, the company managed to maintain a relatively stable operating profit margin, which stood at 31.63% in 2025, up from 21.15% in 2019. This improvement indicates enhanced operational efficiency or cost management. Operating profit (PBDIT) excluding ot..."
      },
      {
        "title": "Tejnaksh Healthcare Falls to 52-Week Low of Rs.16 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-stock-falls-to-52-week-low-of-rs16-3744355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TejnakshHealthc_priceRelatedfactors_3744355.png",
        "date": "2025-12-03 13:50:14",
        "description": "Tejnaksh Healthcare’s stock price reached a fresh 52-week low of Rs.16 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the healthcare services sector."
      },
      {
        "title": "Tejnaksh Healthcare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-stock-rating-upgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3734773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TejnakshHealthc_mojoScore_3734773.png",
        "date": "2025-11-28 08:10:25",
        "description": "Tejnaksh Healthcare, a player in the healthcare services sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. This article analyses the factors influencing the recent shift in the company’s investment outlook, providing investors with a comprehensive understanding of its current position."
      },
      {
        "title": "Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.16.02",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-stock-falls-to-52-week-low-of-rs1602-3725724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TejnakshHealthc_priceRelatedfactors_3725724.png",
        "date": "2025-11-24 14:41:59",
        "description": "Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.16.02 today. This marks a significant decline amid broader market fluctuations and ongoing challenges within the healthcare services sector."
      },
      {
        "title": "Tejnaksh Healthcare Sees Adjustment in Evaluation Amid Technical and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3715043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TejnakshHealthc_mojoScore_3715043.png",
        "date": "2025-11-19 08:16:21",
        "description": "Tejnaksh Healthcare, a key player in the Healthcare Services sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the recent adjustment in the company’s score grade as of 19 Nov 2025, providing investors with a comprehensive overview of its current standing."
      },
      {
        "title": "How has been the historical performance of Tejnaksh Health.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-tejnaksh-health-3713185",
        "imagepath": "",
        "date": "2025-11-18 22:59:29",
        "description": "Answer:\nThe historical performance of Tejnaksh Health shows a fluctuating trend in net sales and profitability over the years. \n\nBreakdown:\nTejnaksh Health's net sales increased from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, showing a steady growth trend. However, this is a decline from a peak of 19.76 Cr in Mar'19. The total operating income followed a similar pattern, rising to 12.90 Cr in Mar'25 from 12.18 Cr in Mar'24, yet down from 16.76 Cr in Mar'20. The total expenditure, excluding depreciation, has gradually increased to 8.82 Cr in Mar'25 from 8.04 Cr in Mar'23, indicating rising operational costs. Operating profit (PBDIT) improved to 4.48 Cr in Mar'25 from 3.94 Cr in Mar'24, although it remains lower than the 5.73 Cr recorded in Mar'19. Profit before tax also rose to 3.19 Cr in Mar'25, up from 2.38 Cr in Mar'24, while profit after tax increased to 2.23 Cr in Mar'25 from 1.76 Cr in Mar'24. The compa..."
      },
      {
        "title": "Why is Tejnaksh Health. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-tejnaksh-health-fallingrising-3713077",
        "imagepath": "",
        "date": "2025-11-18 22:52:21",
        "description": "As of 18-Nov, Tejnaksh Healthcare Ltd's stock price is currently at Rs 16.50, reflecting a decrease of Rs 0.27 or 1.61%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 3.34% during this period. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 1.82% away from Rs 16.2. While there has been a rise in investor participation, with delivery volume increasing by 28.9% against the 5-day average, the overall performance remains weak, as evidenced by the stock's year-to-date decline of 26.70% compared to the Sensex's gain of 8.36%.\n\nIn the broader market context, Tejnaksh Healthcare's recent performance contrasts sharply with the benchmark Sensex, which has shown positive returns over various periods, including a 0.96% in..."
      }
    ],
    "total": 143,
    "sid": "999962",
    "stock_news_url": "https://www.marketsmojo.com/news/tejnaksh-healthcare-999962"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "08-Nov-2025",
      "details": "In continuation of our Letter dated 1st November 2025 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday 8th November 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060 to at 5.00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2025 and took note of Limited Review Report thereon in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; The meeting of Board of Directors commenced at 5.00 p.m. and concluded at 10.00 pm",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025",
      "datetime": "08-Nov-2025",
      "details": "Please find enclosed financial result for the quarter ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window",
      "datetime": "02-Nov-2025",
      "details": "Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 08th November 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th September 2025. 2. Any other matter with the permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 19 Jul 23",
          "dt": "2023-07-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>36:10</strong> bonus issue, ex-date: 26 Apr 18",
          "dt": "2018-04-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Tejnaksh Healthcare Faces Market Assessment Shift Amidst Challenging Financial and Technical Trends

2025-12-04 08:14:52

Tejnaksh Healthcare, a player in the healthcare services sector, has recently experienced a notable shift in market evaluation metrics. This change reflects a complex interplay of technical indicators, valuation considerations, financial trends, and quality assessments, highlighting the challenges the company faces amid a subdued market environment and persistent underperformance relative to benchmarks.

Why is Tejnaksh Health. falling/rising?

2025-12-04 00:48:39

Extended Underperformance Against Benchmarks

Tejnaksh Healthcare's recent price action reflects a persistent weakness relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.82%, markedly worse than the Sensex's modest 0.59% loss. The one-month performance further emphasises this divergence, with Tejnaksh Healthcare falling 11.76% while the Sensex gained 1.34%. Year-to-date figures reveal an even starker contrast: the stock has lost 30.70% of its value, whereas the Sensex has appreciated by 8.92%. This underperformance extends over longer horizons, with the stock down 34.73% over the last year and a staggering 73.93% over three years, while the Sensex has delivered positive returns of 5.27% and 35.37% respectively during these periods.

...

How has been the historical performance of Tejnaksh Health.?

2025-12-03 22:51:13

Revenue and Profitability Trends

Over the seven-year period ending March 2025, Tejnaksh Health.'s net sales demonstrated a downward trend from ₹19.76 crores in 2019 to ₹12.90 crores in 2025. The peak sales were recorded in 2019, followed by a notable decline in subsequent years, with a slight recovery in the latest fiscal year. Total operating income mirrored this pattern, reflecting the company’s core business activity without other operating income contributions, which remained nil throughout.

Despite the decline in sales, the company managed to maintain a relatively stable operating profit margin, which stood at 31.63% in 2025, up from 21.15% in 2019. This improvement indicates enhanced operational efficiency or cost management. Operating profit (PBDIT) excluding ot...

Tejnaksh Healthcare Falls to 52-Week Low of Rs.16 Amid Continued Downtrend

2025-12-03 13:50:14

Tejnaksh Healthcare’s stock price reached a fresh 52-week low of Rs.16 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the healthcare services sector.

Tejnaksh Healthcare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-28 08:10:25

Tejnaksh Healthcare, a player in the healthcare services sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. This article analyses the factors influencing the recent shift in the company’s investment outlook, providing investors with a comprehensive understanding of its current position.

Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.16.02

2025-11-24 14:41:59

Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.16.02 today. This marks a significant decline amid broader market fluctuations and ongoing challenges within the healthcare services sector.

Tejnaksh Healthcare Sees Adjustment in Evaluation Amid Technical and Financial Trends

2025-11-19 08:16:21

Tejnaksh Healthcare, a key player in the Healthcare Services sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the recent adjustment in the company’s score grade as of 19 Nov 2025, providing investors with a comprehensive overview of its current standing.

How has been the historical performance of Tejnaksh Health.?

2025-11-18 22:59:29

Answer: The historical performance of Tejnaksh Health shows a fluctuating trend in net sales and profitability over the years. Breakdown: Tejnaksh Health's net sales increased from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, showing a steady growth trend. However, this is a decline from a peak of 19.76 Cr in Mar'19. The total operating income followed a similar pattern, rising to 12.90 Cr in Mar'25 from 12.18 Cr in Mar'24, yet down from 16.76 Cr in Mar'20. The total expenditure, excluding depreciation, has gradually increased to 8.82 Cr in Mar'25 from 8.04 Cr in Mar'23, indicating rising operational costs. Operating profit (PBDIT) improved to 4.48 Cr in Mar'25 from 3.94 Cr in Mar'24, although it remains lower than the 5.73 Cr recorded in Mar'19. Profit before tax also rose to 3.19 Cr in Mar'25, up from 2.38 Cr in Mar'24, while profit after tax increased to 2.23 Cr in Mar'25 from 1.76 Cr in Mar'24. The compa...

Why is Tejnaksh Health. falling/rising?

2025-11-18 22:52:21

As of 18-Nov, Tejnaksh Healthcare Ltd's stock price is currently at Rs 16.50, reflecting a decrease of Rs 0.27 or 1.61%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 3.34% during this period. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 1.82% away from Rs 16.2. While there has been a rise in investor participation, with delivery volume increasing by 28.9% against the 5-day average, the overall performance remains weak, as evidenced by the stock's year-to-date decline of 26.70% compared to the Sensex's gain of 8.36%. In the broader market context, Tejnaksh Healthcare's recent performance contrasts sharply with the benchmark Sensex, which has shown positive returns over various periods, including a 0.96% in...

View All News

Announcement

Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

08-Nov-2025 | Source : BSE

In continuation of our Letter dated 1st November 2025 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday 8th November 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060 to at 5.00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2025 and took note of Limited Review Report thereon in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; The meeting of Board of Directors commenced at 5.00 p.m. and concluded at 10.00 pm

Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025

08-Nov-2025 | Source : BSE

Please find enclosed financial result for the quarter ended 30th September 2025

Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window

02-Nov-2025 | Source : BSE

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 08th November 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th September 2025. 2. Any other matter with the permission of the Chair.